Zhangzhou Pientzehuang Pharmaceutical News and Activities

Zhangzhou Pientzehuang Pharmaceutical is one of the...

• CSI 300;
• Fortune 500 China (#270);
• TOB Iconic 10,000.

Zhangzhou Pientzehuang Pharmaceutical is a company listed under the stock ticker 600436 (CN).

View the org chart displaying its 6 main executives

Most searched biographies at Zhangzhou Pientzehuang Pharmaceutical

• Jinming Huang, General Manager and Director
• Shouying Du, Independent Director
• Wenning Lai, Director

Create your alert
to follow the executive moves at Zhangzhou Pientzehuang Pharmaceutical.

Zhangzhou Pientzehuang Pharmaceutical has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Corden Pharma has announced the acquisition of AmbioPharm  (posted on June 5 2026).
• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott
• Richard Saynor - Chief Executive Officer at Sandoz

Learn more about the Pharmaceuticals industry

Press releases by Zhangzhou Pientzehuang Pharmaceutical

Social media about Zhangzhou Pientzehuang Pharmaceutical

• Zhangzhou Pientzehuang Pharmaceutical on Wikipedia, Google News & Yahoo Finance
• Zhangzhou Pientzehuang Pharmaceutical on LinkedIn, X (Twitter) & YouTube